Jump to content
NEW Coronavirus Forum! Stay safe by staying at home! Be well! ×

Admin

Admin
  • Content Count

    4,420
  • Joined

  • Last visited

Everything posted by Admin

  1. CBD may improve steroid therapy in autoimmune, Covid-19 patients Israeli startup Stero Therapeutics says cannabis component could enhance steroid treatment or enable reduced steroid dosage to avoid negative effects. By Brian Blum JUNE 18, 2020, 8:30 AM Cannabis component CBD may enhance effects of steroids. Image by HQuality via Shutterstock.com Can cannabis help treat Covid-19? Israeli canna-tech startup Stero Therapeutics wanted to find out. But unexpectedly good news threw a hitch in those plans. At the height of the corona crisis, the B
  2. Some autoimmune diseases are work of overzealous T cells, researchers say Scientists at Israel’s Weizmann Institute find that these protective cells combat excess hormones in certain organs; when they misread the situation, illness results By SHOSHANNA SOLOMON 26 May 2020, T cells attacking a cancer cell (frentusha; iStock by Getty Images) Israeli researchers say they have found that autoimmune diseases, such as diabetes or thyroid dysfunctions, are generated by immune cells that become overzealous in their prot
  3. Benlysta Treatment Lowers Disease Activity for SLE Patients, Real-world Data Shows MAY 29, 2020 BY INES MARTINS, PHD Treatment with Benlysta (belimumab) induces meaningful and long-lasting reductions in systemic lupus erythematosus (SLE) disease activity, helping a significant proportion of patients achieve durable remission or a status of low disease activity, a study in a real-world Italian population shows. Patients diagnosed in the prior two years, with low da
  4. Israeli invention turns tap water into antiviral solution It sounds like magic, but Bar-Ilan University researchers say the environmentally friendly disinfectant may be used daily to kill bacteria and viruses on all kinds of surfaces. By Abigail Klein Leichman APRIL 26, 2020, 8:42 AM Illustrative photo via Shutterstock.com Bacteria and viruses can be killed effectively through a new method that instantly turns ordinary tap water into a powerful, environmentally friendly disinfectant on demand. The technology was developed by chemists at Bar
  5. Everything you need to know about coronavirus at a glance: From how to avoid the virus to survival while self-isolating and knowing the difference between the flu and Covid-19 The death toll from the coronavirus reached almost 6,000 worldwide last night Across Europe, countries have become crippled and placed in lockdown In Britain, the number of dead doubled, to 21, with new measures coming soon Coronavirus symptoms: what are they and should you see a doctor? By DAILY MAIL REPORTER PUBLISHED: 00:32 GMT, 15 March 2020 | UPDATED: 01:01 GMT, 15 March 2020
  6. Stopping Immunosuppressant Medication During an Infection? Sick-Day Planning for the Coronavirus Outbreak Now is the time to talk to your doctor about what you might do if you were to develop infection symptoms. DO NOT STOP TAKING YOUR MEDICATION WITHOUT YOUR DOCTOR'S KNOWLEDGE! As the coronavirus becomes more widespread across the U.S. and the world, it will be important (not to mention reassuring during these high-anxiety times) to have a sick-day plan in place for people who are im
  7. Coronavirus Facts: What You Need to Know If You Have Chronic Illness or Are Immune-Compromised People with chronic illness that affects the immune system, such as many forms of inflammatory arthritis, are understandably worried — if not downright freaking out — about the spread of this new virus. Here’s what infectious disease experts and rheumatologists want you to know. This article has been updated to reflect new information as of March 8, 2020. Bein
  8. LIVING WITH ARTHRITIS ‘Stay Home as Much as Possible’: The New CDC Advice for Those at High Risk of Coronavirus Complications Here’s more on what these recommendations mean for people with chronic illness and weakened immune systems. The CDC is finally issuing some specific recommendations for coronavirus prevention for those at high risk for complications: Stay at home as much as possible. Make sure yo
  9. So you think you’re about to be in a pandemic? Posted on February 25, 2020 by Ian M Mackay, PhD and Katherine E Arden PhD The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [1]) has spread to over 30 countries and regions outside mainland China. Currently, disease spread in Singapore is being slowed by their expertise but new case numbers in South Korea, Italy and Iran, and the wide national distribution of cases in Japan are all signs that the virus is ahead of our efforts to contain it. Let’s go shopping. But bit by bit – not in a rush.
  10. Saving the lives of stroke victims by streamlining workflow After a stroke, every minute of delay can be fatal. Viz.ai monitors CT images for signs of large vessel occlusion in under 30 minutes, and alerts the medical team immediately. By Brian Blum MARCH 3, 2020 CT scans of the human brain. Photo by Shutterstock The biggest cause of death or debilitation from stroke is time to treatment. It’s not a matter of training but of workflow automation. CT scans need to be analyzed immediately, then sent to the right expert. If a particular facilit
  11. Israeli company develops rapid diagnostic kit for COVID-19 ‘This kit has undergone testing by several central laboratories and hospitals that have now verified its ability to diagnose COVID-19.’ By Abigail Klein Leichman MARCH 1, 2020, 3:33 PM BATM’s rapid diagnostic array. Photo: courtesy Israeli company BATM of Hod Hasharon announced that its biomedical division has developed a diagnostics kit to detect coronavirus from saliva samples in less than half an hour. CEO Dr. Zvi Marom tells ISRAEL21c that the test is compatible with the current hospital-based
  12. Israeli MDs give free counseling to coronavirus patients Physicians from some of Israel’s largest hospitals have volunteered for the Innonation social project geared to helping isolated patients all over the world. By Abigail Klein Leichman MARCH 1, 2020 Illustrative photo by Mongkolchon Akesin via Shutterstock.com Thanks to a new social-action project, Chinese coronavirus patients were able to ask Israeli primary care physician Dr. Rachel Libenson Vansh how to maintain proper health and hygiene while confined at home. Using a Zoom video link ove
  13. What is the Coronavirus? The coronavirus belongs to a large family of viruses identified as the cause of certain animal diseases and can cause disease in humans, too. The name 'coronavirus' refers to their resemblance to a crown (corona in Latin) when viewed in an electron microscope. The severity of human illness depends on the particular virus strand of this family and ranges between mild ailment, such as a cold, up to a serious disease that can negatively affect the lungs and lead to multiple organ failure, such as the Middle East Respiratory Syndrome (MERS) and Severe Acute Respirator
  14. Guidance Coronavirus (COVID-19): latest information and advice Information for the public on the outbreak of coronavirus, including the current situation in the UK and information about the virus and its symptoms. Published 24 January 2020 Last updated 3 March 2020 — see all updates From: Department of Health and Social Care and Public Health England Contents Number of cases Risk level
  15. Overview-Coronavirus (COVID-19) Contents Overview Advice for travellers Common questions COVID-19 is a new illness that can affect your lungs and airways. It's caused by a virus called coronavirus. What's the risk of coronavirus in the UK? The UK Chief Medical Officers have raised the risk to the public from low to moderate. Health professionals are working to contact anyone who has been in close contact with people who have coronavirus. What's the risk of coronavi
  16. Lupus Patients Receiving More Quality Clinical Care Report Better Health Outcomes, Study Finds FEBRUARY 12, 2020 BY STEVE BRYSON PHD https://lupusnewstoday.com/2020/02/12/patient-receiving-more-quality-clinical-care-report-lower-disease-activity-damage-study/?utm_source=LUP+NEws+E-mail+List&utm_campaign=17fbd096f4-RSS_WEEKLY_EMAIL_CAMPAIGN_US&utm_medium=email&utm_term=0_50dac6e56f-17fbd096f4-71887989 People with systemic lupus erythemat
  17. JANUARY 15, 2020 IQRA MUMAL, MSC BioMed X and Merck are establishing a combined research group that will focus on the role of the gut epithelial barrier in the development and progression of autoimmune diseases, including systemic lupus erythematosus (SLE) and multiple sclerosis
  18. JANUARY 17, 2020 JOANA CARVALHO, MSC Excessive production of type I interferon (IFN-I) — a molecule that mediates immune and inflammatory responses — in people with systemic lupus erythematosus (SLE) may be caused by small fragments of mitochondrial DNA (mtDNA) that are released upon damage, a study suggested. The study, “VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease,” was published in the journal Science. Mitochondria are the s
  19. January 16, 2020 The Lupus Research Alliance has invested millions in research to get us to the point we’re at with potential new treatments for LN. We are proud to share what just ten of our funded scientists are doing right now to discover what causes lupus nephritis and how it can be better diagnosed, monitored and treated. With our largest grant, the Distinguished Innovator Award, Nir Hacohen at Broad Institute is studying which specific cells are responsible for injuring the kidneys of people with lupus. His aim is to provide new targets for treatments that prevent this damag
  20. January 16, 2020 Up to half of people with lupus will have lupus nephritis – damage to the kidneys that affects the ability to clear the body of wastes and toxins. In 2020, we expect to see significant progress in new drug development for lupus and lupus nephritis in particular with submissions for FDA approval in progress and many opportunities to join studies exploring other potential treatments! Two companies – GSK and Aurinia Pharmaceuticals – expect to go to the U.S. Food and Drug Administration (FDA) for approval of their drugs to treat lupus nephritis based on positive Phase
  21. December 17, 2019 The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive clinical trial results in treating lupus nephritis (LN), a common complication of lupus causing inflammation of the kidneys that can result in end-stage kidney disease. Called BLISS-LN, this Phase 3 trial is the largest one ever conducted among patients with lupus nephritis and paves the way for a new treatment for this disease. Although belimumab is already approved by the U.S. FDA to treat systemic lupus erythematosus (SLE), it had not been test
  22. December 18, 2019 The Lupus Research Alliance (LRA) welcomes additional positive results published today in the New England Journal of Medicine online edition from AstraZeneca’s Phase 3 TULIP-2 trial studying the investigational biologic anifrolumab as a treatment for systemic lupus erythematosus (SLE or lupus). The new study provides further details showing that anifrolumab, which targets type I interferon, met its primary endpoint to significantly lessen disease activity. Of those treated with anifrolumab, 47.8 percent responded to treatment compared with 31.5 percent of those given a
  23. January 6, 2020 New research published in Arthritis and Rheumatology shows that peripheral nervous system (PNS) disease is an important part of neuropsychiatric lupus with significant effects on quality of life. The peripheral nervous system is the network that sends signals between the brain and spinal cord (the central nervous system) with all the other parts of the body. Many of the scientists who participated in this study are part of the leadership of the LRA affiliate Lupus Therapeutics and its Lupus Clinical Trials Network (LuCIN). Conducted at research centers throughout th
  24. January 7, 2020 2019 was a phenomenal, breakthrough year for lupus research on both the clinical development and basic science fronts. The Lupus Research Alliance (LRA) is incredibly proud that every new discovery leading to a brand new medicine for lupus had its origin in work funded by LRA years ago. The past 12 months delivered many exciting “firsts” for lupus — three positive Phase III clinical trials, Fast Track and Breakthrough Therapy designations from the U.S. Food and Drug Administration including one in lupus nephritis (a serious form of lupus affecting the kidneys), and th
  25. JANUARY 8, 2020 Using glucocorticoids to treat inflammation in systemic lupus erythematosus (SLE) was associated with organ damage in patients without active disease, a large study found. These findings draw attention to the possible harmful effects of glucocorticoids — a type of corticosteroid hormone — and indicate that these therapies should be avoided by p
×
×
  • Create New...

Important Information